Walgreens Boots Alliance (NASDAQ:WBA) Issues FY 2025 Earnings Guidance

Walgreens Boots Alliance (NASDAQ:WBA) updated its FY 2025 earnings guidance on Friday. The company provided EPS guidance of 1.400-1.800 for the period, compared to the consensus EPS estimate of 1.520. The company issued revenue guidance of -. Walgreens Boots Alliance also updated its FY25 guidance to $1.40-$1.80 EPS.

Walgreens Boots Alliance Stock Performance

Shares of WBA stock opened at $11.76 on Friday. The stock has a market cap of $10.15 billion, a P/E ratio of -1.17, a P/E/G ratio of 1.36 and a beta of 0.64. The company has a fifty day moving average price of $9.26 and a two-hundred day moving average price of $9.85. Walgreens Boots Alliance has a one year low of $8.08 and a one year high of $24.93. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.68 and a quick ratio of 0.37.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings data on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.38 by $0.13. Walgreens Boots Alliance had a positive return on equity of 14.23% and a negative net margin of 5.85%. The company had revenue of $39.50 billion during the quarter, compared to analysts’ expectations of $37.40 billion. During the same period last year, the firm posted $0.66 earnings per share. The business’s revenue was up 7.6% on a year-over-year basis. As a group, equities analysts predict that Walgreens Boots Alliance will post 1.53 EPS for the current year.

Walgreens Boots Alliance Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, December 12th. Shareholders of record on Monday, November 18th were given a dividend of $0.25 per share. The ex-dividend date of this dividend was Monday, November 18th. This represents a $1.00 annualized dividend and a yield of 8.50%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently -9.99%.

Analyst Ratings Changes

Several analysts recently weighed in on the company. Evercore ISI lifted their price target on Walgreens Boots Alliance from $7.50 to $10.00 and gave the stock an “in-line” rating in a report on Wednesday, October 16th. Royal Bank of Canada reduced their target price on shares of Walgreens Boots Alliance from $13.00 to $9.00 and set a “sector perform” rating for the company in a research report on Wednesday, December 4th. TD Cowen decreased their price target on shares of Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating on the stock in a research note on Tuesday, October 22nd. Jefferies Financial Group cut their price objective on shares of Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating for the company in a report on Wednesday, October 23rd. Finally, UBS Group raised their target price on shares of Walgreens Boots Alliance from $9.00 to $10.00 and gave the stock a “neutral” rating in a report on Thursday, October 17th. Four analysts have rated the stock with a sell rating, nine have issued a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, Walgreens Boots Alliance has an average rating of “Hold” and an average target price of $12.58.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.